Patents by Inventor Diana C. Marquez-Garban

Diana C. Marquez-Garban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING BREAST CANCER
    Publication number: 20230181593
    Abstract: The present disclosure relates to methods and compositions for the treatment of cancer (e.g., breast cancer).
    Type: Application
    Filed: May 21, 2021
    Publication date: June 15, 2023
    Inventors: Nalo M. Hamilton, Diana C. Marquez-Garban, Richard J. Pietras
  • Compositions and methods for treating cancer
    Patent number: 10512630
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Grant
    Filed: September 29, 2016
    Date of Patent: December 24, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • Estrogen receptor modulators
    Patent number: 10400006
    Abstract: Described herein, inter alia, are compositions and methods for treating or preventing hyperproliferative disorders, including cancer.
    Type: Grant
    Filed: November 20, 2015
    Date of Patent: September 3, 2019
    Assignee: The Regents of the University of California
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20180280346
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Application
    Filed: September 29, 2016
    Publication date: October 4, 2018
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • ESTROGEN RECEPTOR MODULATORS
    Publication number: 20180086787
    Abstract: Described herein, inter alia, are compositions and methods for treating or preventing hyperproliferative disorders, including cancer.
    Type: Application
    Filed: November 20, 2015
    Publication date: March 29, 2018
    Inventors: Richard J. PIETRAS, Michael E. JUNG, Diana C. MARQUEZ-GARBAN, Gang DENG
  • Compounds and methods of treating cancer
    Patent number: 9862693
    Abstract: Presented herein inter alia are novel compounds and methods of using the same for the treatment of cancers.
    Type: Grant
    Filed: December 10, 2014
    Date of Patent: January 9, 2018
    Assignee: The Regents of the University of California
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • Compositions and methods for treating cancer
    Patent number: 9512138
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: December 6, 2016
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Márquez-Garbán, Gang Deng
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20160137662
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Application
    Filed: January 7, 2016
    Publication date: May 19, 2016
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Márquez-Garbán, Gang Deng
  • Compositions and methods for treating cancer
    Patent number: 9266901
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Grant
    Filed: October 2, 2014
    Date of Patent: February 23, 2016
    Assignee: The Regents of The University of Califronia
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • COMPOUNDS AND METHODS OF TREATING CANCER
    Publication number: 20150158832
    Abstract: Presented herein inter alia are novel compounds and methods of using the same for the treatment of cancers.
    Type: Application
    Filed: December 10, 2014
    Publication date: June 11, 2015
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20150031725
    Abstract: Provided herein, inter alia, are compositions and methods useful for treating hyperproliferative diseases, including cancer and non-malignant hyperproliferative diseases.
    Type: Application
    Filed: October 2, 2014
    Publication date: January 29, 2015
    Inventors: Richard J. Pietras, Michael E. Jung, Diana C. Marquez-Garban, Gang Deng
  • AROMATASE EXPRESSION PREDICTS SURVIVAL IN WOMEN WITH NON-SMALL CELL LUNG CANCER
    Publication number: 20100331203
    Abstract: The present invention relates to the discovery that the level of aromatase polypeptide expression in non-small cell lung carcinomas can be used for example to provide information useful in prognostic and therapeutic methodologies in women having or suspected of having this cancer.
    Type: Application
    Filed: October 6, 2008
    Publication date: December 30, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Lee Goodglick, Richard J. Pietras, Vei Mah, David B. Seligson, David S. Chia, Diana C. Marquez-Garban, Michael C. Fishbein
  • Membrane estrogen receptor-directed therapy in breast cancer
    Publication number: 20030044412
    Abstract: Methods of diagnosing and treating mammalian tumors with molecules including anti-estrogen receptor immunoglobulin polypeptides are provided. In an illustrative embodiment, anti-estrogen receptor immunoglobulin polypeptides specific to distinct epitopes of the ligand-binding domain of estrogen receptor are contacted with membrane-associated estrogen receptor under conditions which allow binding of the anti-estrogen receptor immunoglobulin polypeptide to a degree sufficient to inhibit tumor growth by inhibiting the activation of the membrane-associated estrogen receptor. Injectable compositions for treating certain mammalian tumors with monoclonal antibodies and methods for diagnosing mammalian cancers which express an estrogen receptor associated with the surface membrane of the cells are also disclosed. Further, alternate methods for blocking intracellular signal transduction emanating from the activation of membrane-associated estrogen receptor forms are also presented.
    Type: Application
    Filed: August 26, 2002
    Publication date: March 6, 2003
    Inventors: Richard J. Pietras, Diana C. Marquez-Garban